Treatment and prevention of hepatic disorders

Details Treatment and prevention of hepatic disorders Treatment and prevention of hepatic disorders

1999-03-23

2000-11-14

Kight, John

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

C-o-group doai

568716, 568780, 514893, 514894, A61K 3105, C07C 3904

Patent

active

061471232

ABSTRACT:
New methods are described for the treatment of viral hepatitis C involving the administration of vitamin E and other compounds with antioxidant properties. Treatment with high doses of vitamin E is effective in treating chronic hepatitis C in patients refractory to interferon. In addition, new methods are described for the treatment of hepatic fibrosis and hepatic conditions manifesting hepatic fibrosis involving the administration of butylated hydroxytoluene and a metabolite of pentoxifylline, 1-[3-carboxypropyl]-3, 7-dimethylxanthine.

REFERENCES:
McCrmick, D.L. et al.: Anticarcinogenic and hepatotoxic interactions between Retinyl Acetate and Butylated Hydroxytoluene in rats. Cancer Res. vol. 46, pp. 5264-5269, 1986.

Affiliated with

Also associated with

Rating

Treatment and prevention of hepatic disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment and prevention of hepatic disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment and prevention of hepatic disorders will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2065912